Serine Hydrolase Activity-Based Probes for use in Chemical Proteomics

被引:3
作者
Racioppo, Brittney [1 ,2 ]
Qiu, Nan [1 ,2 ]
Adibekian, Alexander [1 ]
机构
[1] Univ Illinois, Dept Chem, Chicago, IL 60607 USA
[2] Scripps Res, Skaggs Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
serine hydrolase; activity-based protein profiling; activity-based probes; serine hydrolase inhibitors; imaging; SELECTIVE INHIBITORS; PROTEASE INHIBITORS; COVALENT INHIBITORS; BETA-SULTAMS; IN-VIVO; IRREVERSIBLE INHIBITORS; REVERSIBLE INHIBITORS; BACTERIAL ENZYMES; HIGH-THROUGHPUT; BINDING-SITE;
D O I
10.1002/ijch.202300016
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Serine hydrolases (SHs) comprise a large superfamily of enzymes that play critical roles in many biological processes. Despite their importance, many SHs remain uncharacterized and the vast majority of SHs lack selective inhibitors. In response, activity-based protein profiling (ABPP) and activity-based probes (ABPs) have been leveraged to construct a more comprehensive picture of the SH proteome. Since the utility of ABPP is largely dictated by the reactivity profile of the ABPs deployed, novel scaffolds and chemotypes are needed to expand the breadth and selectivity of SH-targeting ABPs. In this review, we highlight recent innovations in SH probe development, covering both established and emerging electrophilic warheads. We then discuss how strategic implementation of SH-targeting ABPs has yielded selective, potent inhibitors and imaging agents with broad use. Finally, we present methods for ABP diversification and explore cutting-edge applications in therapeutics development and discovery biology.
引用
收藏
页数:16
相关论文
共 132 条
  • [1] High-Resolution Confocal Fluorescence Imaging of Serine Hydrolase Activity in Cryosections - Application to Glioma Brain Unveils Activity Hotspots Originating from Tumor-Associated Neutrophils
    Aaltonen, Niina
    Singha, Prosanta K.
    Jakupovic, Hermina
    Wirth, Thomas
    Samaranayake, Haritha
    Pasonen-Seppanen, Sanna
    Rilla, Kirsi
    Varjosalo, Markku
    Edgington-Mitchell, Laura E.
    Kasperkiewicz, Paulina
    Drag, Marcin
    Kalvala, Sara
    Moisio, Eemeli
    Savinainen, Juha R.
    Laitinen, Jarmo T.
    [J]. BIOLOGICAL PROCEDURES ONLINE, 2020, 22 (01)
  • [2] Facile synthesis of borofragments and their evaluation in activity-based protein profiling
    Adachi, Shinya
    Cognetta, Armand B., III
    Niphakis, Micah J.
    He, Zhi
    Zajdlik, Adam
    Denis, Jeffrey D. St.
    Scully, Conor C. G.
    Cravatt, Benjamin F.
    Yudin, Andrei K.
    [J]. CHEMICAL COMMUNICATIONS, 2015, 51 (17) : 3608 - 3611
  • [3] Confirming Target Engagement for Reversible Inhibitors in Vivo by Kinetically Tuned Activity-Based Probes
    Adibekian, Alexander
    Martin, Brent R.
    Chang, Jae Won
    Hsu, Ku-Lung
    Tsuboi, Katsunori
    Bachovchin, Daniel A.
    Speers, Anna E.
    Brown, Steven J.
    Spicer, Timothy
    Fernandez-Vega, Virneliz
    Ferguson, Jill
    Hodder, Peter S.
    Rosen, Hugh
    Cravatt, Benjamin F.
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (25) : 10345 - 10348
  • [4] Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]
  • [5] Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism
    Ahn, Kay
    Boehm, Markus
    Brown, Matthew F.
    Calloway, Jessica
    Che, Ye
    Chen, Jinshan
    Fennell, Kimberly F.
    Geoghegan, Kieran F.
    Gilbert, Adam M.
    Gutierrez, Jemy A.
    Kalgutkar, Amit S.
    Lanba, Adhiraj
    Limberalds, Chris
    Magee, Thomas V.
    O'Doherty, Inish
    Oliver, Robert
    Pabst, Brandon
    Pandit, Jayvardhan
    Parris, Kevin
    Pfefferkorn, Jeffrey A.
    Rolph, Timothy P.
    Patel, Rushi
    Schuff, Brandon
    Shanmugasundaram, Veerabahu
    Starr, Jeremy T.
    Varghese, Alison H.
    Vera, Nicholas B.
    Vernochet, Cecile
    Yan, Jiangli
    [J]. ACS CHEMICAL BIOLOGY, 2016, 11 (09) : 2529 - 2540
  • [6] Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain
    Ahn, Kay
    Smith, Sarah E.
    Liimatta, Marya B.
    Beidler, David
    Sadagopan, Nalini
    Dudley, David T.
    Young, Tim
    Wren, Paul
    Zhang, Yanhua
    Swaney, Steven
    Van Becelaere, Keri
    Blankman, Jacqueline L.
    Nomura, Daniel K.
    Bhattachar, Shobha N.
    Stiff, Cory
    Nomanbhoy, Tyzoon K.
    Weerapana, Eranthie
    Johnson, Douglas S.
    Cravatt, Benjamin F.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01) : 114 - 124
  • [7] Sulfonyl Fluoride Inhibitors of Fatty Acid Amide Hydrolase
    Alapafuja, Shakiru O.
    Nikas, Spyros P.
    Bharathan, Indu T.
    Shukla, Vidyanand G.
    Nasr, Mahmoud L.
    Bowman, Anna L.
    Zvonok, Nikolai
    Li, Jing
    Shi, Xiaomeng
    Engen, John R.
    Makriyannis, Alexandros
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 10074 - 10089
  • [8] Bachovchin DA, 2014, NAT CHEM BIOL, V10, P656, DOI [10.1038/NCHEMBIO.1578, 10.1038/nchembio.1578]
  • [9] The pharmacological landscape and therapeutic potential of serine hydrolases
    Bachovchin, Daniel A.
    Cravatt, Benjamin F.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (01) : 52 - 68
  • [10] Superfamily-wide portrait of serine hydrolase inhibition achieved by library-versus-library screening
    Bachovchin, Daniel A.
    Ji, Tianyang
    Li, Weiwei
    Simon, Gabriel M.
    Blankman, Jacqueline L.
    Adibekian, Alexander
    Hoover, Heather
    Niessen, Sherry
    Cravatt, Benjamin F.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (49) : 20941 - 20946